Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis
- PMID: 10385672
- DOI: 10.1002/hep.510300139
Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis
Abstract
Dominant negative (DN) mutants of the hepadnaviral core protein are potent inhibitors of viral replication. We have previously shown that fusion of sequences derived from the duck hepatitis B virus (DHBV) polymerase (Pol), DHBV small surface protein (S), bacterial beta-galactosidase (lacZ), or green fluorescent protein (GFP) to the carboxy terminus of the DHBV core protein yields DN mutants that inhibit viral replication at the posttranslational level. To elucidate the mechanism(s) of their antiviral action, we analyzed the effect of the DN mutants on RNA pregenome packaging and nucleocapsid assembly. Core-Pol and core-S, but not core-lacZ or core-GFP, markedly interfered with RNA pregenome packaging. Nucleocapsid formation was not affected by any of the mutants. The DN core-GFP fusion protein formed mixed particles with wild-type core protein in the cytoplasm of cotransfected cells and interfered with reverse transcription of the viral pregenome. A subpopulation of chimeric nucleocapsids, however, was shown to overcome the block in DNA synthesis and produce mature viral DNA. Thus, at least 2 steps within the viral life cycle can be targeted by DN DHBV core proteins: 1) packaging of the viral pregenome; and 2) reverse transcription within mixed particles. The fact that some mixed particles retain replication competence demonstrates a high structural flexibility of nucleocapsids and indicates a possible mechanism of viral escape.
Similar articles
-
Cis-preferential recruitment of duck hepatitis B virus core protein to the RNA/polymerase preassembly complex.Hepatology. 2002 Jan;35(1):209-16. doi: 10.1053/jhep.2002.30086. Hepatology. 2002. PMID: 11786978
-
Inhibition of viral replication by genetically engineered mutants of the duck hepatitis B virus core protein.Hepatology. 1996 Aug;24(2):294-9. doi: 10.1002/hep.510240202. Hepatology. 1996. PMID: 8690395
-
Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents.Hepatology. 1996 Nov;24(5):1010-7. doi: 10.1002/hep.510240506. Hepatology. 1996. PMID: 8903368
-
Mechanisms governing hepadnaviral nucleocapsid assembly.J Hepatol. 1993;17 Suppl 3:S15-9. doi: 10.1016/s0168-8278(05)80418-0. J Hepatol. 1993. PMID: 8509632 Review.
-
Hepatitis B virus replication.World J Gastroenterol. 2007 Jan 7;13(1):48-64. doi: 10.3748/wjg.v13.i1.48. World J Gastroenterol. 2007. PMID: 17206754 Free PMC article. Review.
Cited by
-
Gene therapeutic approaches to inhibit hepatitis B virus replication.World J Hepatol. 2015 Feb 27;7(2):150-64. doi: 10.4254/wjh.v7.i2.150. World J Hepatol. 2015. PMID: 25729471 Free PMC article. Review.
-
Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses.J Virol. 2000 May;74(10):4721-8. doi: 10.1128/jvi.74.10.4721-4728.2000. J Virol. 2000. PMID: 10775610 Free PMC article.
-
VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication.World J Gastroenterol. 2005 Nov 7;11(41):6429-32. doi: 10.3748/wjg.v11.i41.6429. World J Gastroenterol. 2005. PMID: 16425411 Free PMC article.
-
Inhibition on Hepatitis B virus in vitro of recombinant MAP30 from bitter melon.Mol Biol Rep. 2009 Feb;36(2):381-8. doi: 10.1007/s11033-007-9191-2. Epub 2007 Dec 5. Mol Biol Rep. 2009. PMID: 18058255
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources